Skip to main content
. 2022 Feb 27;37(5):954–968. doi: 10.1093/humrep/deac035

Figure 2.

Figure 2.

Forest plots describing breast cancer recurrence, event-free survival and mortality in patients undergoing controlled ovarian stimulation before starting oncological treatments. Solid vertical line: Significance line (line of no effect). Gray squares: represents the weighted mean (point estimate) of each study. Horizontal bars: 95% CI line. Diamond: represents the mean of effect sizes obtained by the meta-analysis. Its width corresponds to its 95% CI. (A) Recurrence rate in patients undergoing COS. (B) Event-free survival in patients undergoing COS. (C) Mortality rate in patients undergoing COS. COS, controlled ovarian stimulation; HR, hazard ratio; RR, relative risk. I-squared is Higgins I2 index (Higgins and Thompson, 2002).